Table 1.
Cross-reactivity of neutralizing antibodies to AAV-LK03, 3B, and 8 in humans
| AAV-LK03 | AAV3B | AAV8 | |
|---|---|---|---|
| AAV-LK03 | — | 97% | 61% |
| AAV3B | 67% | — | 47% |
| AAV8 | 79% | 87% | — |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.